インスリンデテミルは，体重増加なく血糖コントロールを改善させる―NPHからの切り替え例での検討―

P Kurtzhals, S Havelund, I Jonassen, B Kiehr, U D Larsen, U Ribel, J Markussen, Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo Biochemical Journal. ,vol. 312, pp. 725- 731 ,(1995) , 10.1042/BJ3120725

G. B. Bolli, G. Perriello, C. G. Fanelli, P. De Feo, Nocturnal blood glucose control in type I diabetes mellitus. Diabetes Care. ,vol. 16, pp. 71- 89 ,(1993) , 10.2337/DIACARE.16.3.71

Philip Home, Paul Bartley, David Russell-Jones, Hélène Hanaire-Broutin, Jan-Evert Heeg, Pascale Abrams, Mona Landin-Olsson, Birgitte Hylleberg, Hanne Lang, Eberhard Draeger, Study to Evaluate the Administration of Detemir Insulin Efficacy, Safety and Suitability (STEADINESS) Study Group, None, Insulin Detemir Offers Improved Glycemic Control Compared With NPH Insulin in People With Type 1 Diabetes: A randomized clinical trial. Diabetes Care. ,vol. 27, pp. 1081- 1087 ,(2004) , 10.2337/DIACARE.27.5.1081

K. V. Hendriksen, T. Jensen, P. Oturai, B. Feldt-Rasmussen, Effects of insulin detemir and NPH insulin on renal handling of sodium, fluid retention and weight in type 2 diabetic patients. Diabetologia. ,vol. 55, pp. 46- 50 ,(2012) , 10.1007/S00125-011-2345-8

Yasuo Ohkubo, Hideki Kishikawa, Eiichi Araki, Takao Miyata, Satoshi Isami, Sadatoshi Motoyoshi, Yujiro Kojima, Naohiko Furuyoshi, Motoaki Shichiri, Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Research and Clinical Practice. ,vol. 28, pp. 103- 117 ,(1995) , 10.1016/0168-8227(95)01064-K

S. V. M. Hordern, J. E. Wright, A. M. Umpleby, F. Shojaee-Moradie, J. Amiss, D. L. Russell-Jones, Comparison of the effects on glucose and lipid metabolism of equipotent doses of insulin detemir and NPH insulin with a 16-h euglycaemic clamp. Diabetologia. ,vol. 48, pp. 420- 426 ,(2005) , 10.1007/S00125-005-1670-1

A. M. Hennige, T. Sartorius, O. Tschritter, H. Preissl, A. Fritsche, P. Ruth, H.-U. Häring, Tissue selectivity of insulin detemir action in vivo. Diabetologia. ,vol. 49, pp. 1274- 1282 ,(2006) , 10.1007/S00125-006-0192-9

T. Heise, C. Weyer, A. Serwas, S. Heinrichs, J. Osinga, P. Roach, J. Woodworth, U. Gudat, L. Heinemann, Time-Action Profiles of Novel Premixed Preparations of Insulin Lispro and NPL Insulin Diabetes Care. ,vol. 21, pp. 800- 803 ,(1998) , 10.2337/DIACARE.21.5.800

T Haak, A Tiengo, E Draeger, M Suntum, W Waldhäusl, None, Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes Diabetes, Obesity and Metabolism. ,vol. 7, pp. 56- 64 ,(2005) , 10.1111/J.1463-1326.2004.00373.X

P. Vague, J.-L. Selam, S. Skeie, I. De Leeuw, J. W.F. Elte, H. Haahr, A. Kristensen, E. Draeger, Insulin Detemir Is Associated With More Predictable Glycemic Control and Reduced Risk of Hypoglycemia Than NPH Insulin in Patients With Type 1 Diabetes on a Basal-Bolus Regimen With Premeal Insulin Aspart Diabetes Care. ,vol. 26, pp. 590- 596 ,(2003) , 10.2337/DIACARE.26.3.590